Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BDSX · NASDAQ · Services-Medical Laboratories
Biodesix (BDSX) · oqro.io/stocks/BDSX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$9.88+0.09 (+0.92%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
2 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
First insider buy since Sep 2025Traded Nov 10 · filed 2 days later
Since the trade −1.4% · S&P 500 +0.6% · to Nov 13
A major shareholder of Biodesix paid $1M out of pocket for Biodesix shares. It was the first purchase in over a year. Shares held went up 18% with this purchase.
Insider buying
Traded Sep 19, 2025 · filed 4 days later
Since the trade +38.6% · S&P 500 +13.7% · to Nov 13
A Biodesix director paid $1M out of pocket for Biodesix shares. Shares held went up 12% with this purchase.
Traded Sep 17 – Sep 18, 2025 · largest single transaction ~$93K
Sep 17, 2025~$93K · 15K sh @ $6.04
DetailsOfficial recordInsider buying
Traded Aug 29, 2025 · filed 5 days later
Since the trade +15.8% · S&P 500 +16.9% · to Nov 13
A Biodesix director paid $1.5M out of pocket for Biodesix shares. Shares held went up 17% with this purchase.
Scott Hutton (President & CEO) sold ~$1.6K of Biodesix
Automatic saleRobin Harper Cowie (CFO, Sec'y & Treasurer) sold ~$411 of Biodesix
Automatic saleGary Anthony Pestano (Chief Development Officer) sold ~$184 of Biodesix
Automatic saleKieran O'kane (Chief Commercial Officer) sold ~$198 of Biodesix
Automatic saleChris Vazquez (Chief Accounting Officer) sold ~$95 of Biodesix
Automatic saleTraded May 16 – May 19, 2025 · largest single transaction ~$1.07M
May 16, 2025~$1.07M · 4M sh @ $0.2675
DetailsOfficial recordScott Hutton (President & CEO) sold ~$679 of Biodesix
Automatic saleScott Hutton (President & CEO) sold ~$666 of Biodesix
Automatic saleRobin Harper Cowie (CFO, Sec'y & Treasurer) sold ~$178 of Biodesix
Automatic saleRobin Harper Cowie (CFO, Sec'y & Treasurer) sold ~$175 of Biodesix
Automatic saleChris Vazquez (Chief Accounting Officer) sold ~$40 of Biodesix
Automatic saleKieran O'kane (Chief Commercial Officer) sold ~$86 of Biodesix
Automatic saleKieran O'kane (Chief Commercial Officer) sold ~$84 of Biodesix
Automatic saleGary Anthony Pestano (Chief Development Officer) sold ~$80 of Biodesix
Automatic saleGary Anthony Pestano (Chief Development Officer) sold ~$78 of Biodesix
Automatic saleChris Vazquez (Chief Accounting Officer) sold ~$40 of Biodesix
Automatic saleScott Hutton (President & CEO) sold ~$77K of Biodesix
Automatic saleRobin Harper Cowie (CFO, Sec'y & Treasurer) sold ~$23K of Biodesix
Automatic saleKieran O'kane (Chief Commercial Officer) sold ~$16K of Biodesix
Automatic saleGary Anthony Pestano (Chief Development Officer) sold ~$15K of Biodesix
Automatic saleChris Vazquez (Chief Accounting Officer) sold ~$3.4K of Biodesix
Automatic saleInsider buying
Traded Nov 21, 2024 · filed 1 day later
Since the trade −58.8% · S&P 500 +27.1% · to Nov 13
A Biodesix director paid $123K out of pocket for Biodesix shares. 4 other people at Biodesix bought some too, in the same month.
Insider buying
Traded Nov 21, 2024 · filed 1 day later
Since the trade −58.8% · S&P 500 +27.1% · to Nov 13
A Biodesix director paid $41K out of pocket for Biodesix shares. 4 other people at Biodesix bought some too, in the same month.
Insider buying
Traded Nov 20, 2024 · filed 1 day later
Since the trade −58.5% · S&P 500 +27.8% · to Nov 13
A Biodesix director paid $234K out of pocket for Biodesix shares. 4 other people at Biodesix bought some too, in the same month.
Scott Hutton (President & CEO) sold ~$2.7K of Biodesix
Automatic saleScott Hutton (President & CEO) sold ~$2.5K of Biodesix
Automatic saleRobin Harper Cowie (CFO, Sec'y & Treasurer) sold ~$660 of Biodesix
Automatic saleRobin Harper Cowie (CFO, Sec'y & Treasurer) sold ~$695 of Biodesix
Automatic saleKieran O'kane (Chief Commercial Officer) sold ~$331 of Biodesix
Automatic saleKieran O'kane (Chief Commercial Officer) sold ~$314 of Biodesix
Automatic saleGary Anthony Pestano (Chief Development Officer) sold ~$306 of Biodesix
Automatic saleGary Anthony Pestano (Chief Development Officer) sold ~$290 of Biodesix
Automatic saleChris Vazquez (Chief Accounting Officer) sold ~$146 of Biodesix
Automatic saleChris Vazquez (Chief Accounting Officer) sold ~$137 of Biodesix
Automatic saleSep 18, 2025~$19K · 3,056 sh @ $6.17
DetailsOfficial recordMay 19, 2025~$247K · 723K sh @ $0.341
DetailsOfficial record1 open-market purchase and 0 open-market sales by insiders of BDSX between Jan 27, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026. The data provider lists the next release for Feb 24, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | None | None | 1 purchase |
| Aug 5, 2026 | None | None | None |
| May 4, 2026 | None | None | None |
| Feb 26, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
